Trilafon
Trilafon, also known as perphenazine, is an antipsychotic indicated for
the treatment of mental and emotional disorders such as schizophrenia
as well as for the control of severe nausea and vomiting in adults. Trilafon
controls symptoms of psychotic disorder, including hallucinations, delusions
and hostility. The medication comes as a tablet and liquid concentrate
to take by mouth. It usually is taken three times a day. Made by Schering-Plough,
Trilafon was approved by the U.S. Food and Drug Administration in 1957.
Potential side effects of Trilafon use include, but may not be limited
to, drowsiness, dizziness, vision problems, constipation, digestive disorders,
headache, dry mouth and weight gain.
|
